Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/37549
Title: | Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum. | |
Authors: | ||
Keywords: | ||
Mesh: | ||
Issue Date: | 2018 | |
Citation: | BMC Med. Genet..2018 03;(19)1:36 | |
Abstract: | Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder characterized by broad thumbs and halluces. RSTS is caused by mutations in CREBBP and in EP300 genes in 50-60% and 8%, respectively. Up to now, 76 RSTS-EP300 patients have been described. We present the clinical and molecular characterization of a cohort of RSTS patients carrying EP300 mutations. | |
PMID: | 29506490 | |
URI: | https://hdl.handle.net/20.500.12530/37549 | |
Rights: | openAccess | |
Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos | |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PMC5839060.pdf | 2.83 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.